GB0328314D0 - Therapeutics - Google Patents
TherapeuticsInfo
- Publication number
- GB0328314D0 GB0328314D0 GBGB0328314.0A GB0328314A GB0328314D0 GB 0328314 D0 GB0328314 D0 GB 0328314D0 GB 0328314 A GB0328314 A GB 0328314A GB 0328314 D0 GB0328314 D0 GB 0328314D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0328314.0A GB0328314D0 (en) | 2003-12-05 | 2003-12-05 | Therapeutics |
AU2004295178A AU2004295178A1 (en) | 2003-12-05 | 2004-12-06 | Therapeutics use of pyridinium compounds to modulate NAADP activity |
CA002547791A CA2547791A1 (en) | 2003-12-05 | 2004-12-06 | Therapeutics use of pyridinium compounds to modulate naadp activity |
PCT/GB2004/005109 WO2005054198A2 (en) | 2003-12-05 | 2004-12-06 | Therapeutics use of pyridinium compounds to modulate naadp activity |
EP04801265A EP1689714A2 (en) | 2003-12-05 | 2004-12-06 | Therapeutic use of pyridinium compounds to modulate naadp activity |
JP2006542024A JP2007516964A (en) | 2003-12-05 | 2004-12-06 | Use of pyridinium compounds as therapeutics to modulate NAADP activity |
US11/422,010 US20070105810A1 (en) | 2003-12-05 | 2006-06-02 | Therapeutics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0328314.0A GB0328314D0 (en) | 2003-12-05 | 2003-12-05 | Therapeutics |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0328314D0 true GB0328314D0 (en) | 2004-01-07 |
Family
ID=29764706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0328314.0A Ceased GB0328314D0 (en) | 2003-12-05 | 2003-12-05 | Therapeutics |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1689714A2 (en) |
JP (1) | JP2007516964A (en) |
AU (1) | AU2004295178A1 (en) |
CA (1) | CA2547791A1 (en) |
GB (1) | GB0328314D0 (en) |
WO (1) | WO2005054198A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007132179A2 (en) * | 2006-05-15 | 2007-11-22 | University Of Bath | Therapeutics comprising pyridinium derivatives |
CN102491944A (en) * | 2011-12-13 | 2012-06-13 | 东阳市威达环保助剂有限公司 | Method for preparing brominated 1-benzyl-3-carboxypyridine and preparation method thereof |
JP2023509947A (en) * | 2020-01-10 | 2023-03-10 | オーフス ウニベルシテット | A compound for promoting follicular maturation |
CN113277977B (en) * | 2021-05-25 | 2022-10-04 | 德锡化学(山东)有限公司 | Trigonelline compound and synthesis method and application thereof |
WO2023230205A1 (en) | 2022-05-25 | 2023-11-30 | Ikena Oncology, Inc. | Mek inhibitors and uses thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001519813A (en) * | 1997-04-04 | 2001-10-23 | スミスクライン・ビーチャム・コーポレイション | Calcium soluble compounds |
GB9712370D0 (en) * | 1997-06-14 | 1997-08-13 | Aepact Ltd | Therapeutic systems |
WO1999036422A1 (en) * | 1998-01-14 | 1999-07-22 | The Uab Research Foundation | Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme |
GB9804175D0 (en) * | 1998-02-28 | 1998-04-22 | Zeneca Ltd | Compounds |
CZ20011808A3 (en) * | 1999-10-06 | 2001-08-15 | Torrent Pharmaceuticals Ltd | Compound of the pyridinium series, process of its preparation and use pharmaceutical preparation in it is comprised and use thereof |
GB0019234D0 (en) * | 2000-08-04 | 2000-09-27 | Univ Bath | Therapeutics |
HUP0104831A2 (en) * | 2001-10-19 | 2003-08-28 | Torrent Pharmaceuticals Ltd. | Composition and method for use of pyridinium derivatives in therapeutic applications |
AU2003228610A1 (en) * | 2002-04-19 | 2003-11-03 | University Of Florida | Thyrotropin-releasing hormone analogues and their therapeutic applications |
-
2003
- 2003-12-05 GB GBGB0328314.0A patent/GB0328314D0/en not_active Ceased
-
2004
- 2004-12-06 WO PCT/GB2004/005109 patent/WO2005054198A2/en active Application Filing
- 2004-12-06 CA CA002547791A patent/CA2547791A1/en not_active Abandoned
- 2004-12-06 EP EP04801265A patent/EP1689714A2/en not_active Withdrawn
- 2004-12-06 AU AU2004295178A patent/AU2004295178A1/en not_active Abandoned
- 2004-12-06 JP JP2006542024A patent/JP2007516964A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2005054198A2 (en) | 2005-06-16 |
AU2004295178A1 (en) | 2005-06-16 |
CA2547791A1 (en) | 2005-06-16 |
JP2007516964A (en) | 2007-06-28 |
EP1689714A2 (en) | 2006-08-16 |
WO2005054198A3 (en) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE502004011703D1 (en) | N-heterocyclyl-phenylsubstituierte cyclische ketoenole | |
EP1635758A4 (en) | Orthodynamic rehabilitator | |
EP1615948A4 (en) | Immuno-amplification | |
DE602004012071D1 (en) | T-hilfe | |
DE602004020356D1 (en) | Phenoxyessigsäurederivate | |
DE602004030538D1 (en) | Präzisionssubstratlagerbehälter | |
EP1629178A4 (en) | Rockbolt | |
DE502004009243D1 (en) | Spirocyclische cyclohexan-derivate | |
DE602004027010D1 (en) | Thermotherapiehülle | |
DE502004003476D1 (en) | Standfuss | |
DE502004006683D1 (en) | Injection-locked-oscillator-schaltkreis | |
DE502004011852D1 (en) | Nspritzventil | |
DE502004004146D1 (en) | Pyrazolverbindungen | |
DE112004002769D2 (en) | Schienengeführtes transportsystem | |
DK1665437T3 (en) | Reformeringsmodul | |
DE60333037D1 (en) | Laser-radar | |
DE502004011343D1 (en) | Rotorspinnmaschine | |
DE602004012262D1 (en) | Benzimidazolonverbindung | |
DE602004020525D1 (en) | Imidazolderivate | |
DE502004012153D1 (en) | Rotorspinnmaschine | |
DE10394343D2 (en) | Berührungslose biometrische erkennung | |
GB0328314D0 (en) | Therapeutics | |
DE602004009041D1 (en) | Hydroxytetrahydronaphthalenylharnstoffderivate | |
DE602004008281D1 (en) | Avermectin-b1-monosaccharidderivative | |
EP1698434A4 (en) | Geinder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |